These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 29179183)

  • 1. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
    Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L
    Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
    Panoutsopoulou K; Avgeris M; Scorilas A
    Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes.
    Tripathi MK; Doxtater K; Keramatnia F; Zacheaus C; Yallapu MM; Jaggi M; Chauhan SC
    Drug Discov Today; 2018 Sep; 23(9):1635-1643. PubMed ID: 29698834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Long Non-Coding RNAs in Ovarian Cancer.
    Nikpayam E; Tasharrofi B; Sarrafzadeh S; Ghafouri-Fard S
    Iran Biomed J; 2017 Jan; 21(1):3-15. PubMed ID: 27664137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs: A view to kill ovarian cancer.
    Zamaraev AV; Volik PI; Sukhikh GT; Kopeina GS; Zhivotovsky B
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188584. PubMed ID: 34157315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNAs and neoplasia.
    Isin M; Dalay N
    Clin Chim Acta; 2015 Apr; 444():280-8. PubMed ID: 25748036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of long noncoding RNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer.
    Colvin EK; Howell VM; Mok SC; Samimi G; Vafaee F
    Cancer Sci; 2020 May; 111(5):1805-1817. PubMed ID: 32058624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs in ovarian cancer.
    Zhan L; Li J; Wei B
    J Exp Clin Cancer Res; 2018 Jun; 37(1):120. PubMed ID: 29921308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of non-coding RNA in oral cancer.
    Momen-Heravi F; Bala S
    Cell Signal; 2018 Jan; 42():134-143. PubMed ID: 29056500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
    Fang L; Wang H; Li P
    Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies.
    Zhang F; Zhang L; Zhang C
    Tumour Biol; 2016 Jan; 37(1):163-75. PubMed ID: 26586396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
    Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
    Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer.
    Zhong Y; Gao D; He S; Shuai C; Peng S
    Int J Gynecol Cancer; 2016 Nov; 26(9):1564-1570. PubMed ID: 27603915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs in glioma progression.
    Xi J; Sun Q; Ma L; Kang J
    Cancer Lett; 2018 Apr; 419():203-209. PubMed ID: 29355660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
    Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
    Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.